News
Galapagos, NovAliX Enter Integrated Drug Discovery Collaboration
Galapagos NV entered into a strategic collaboration with NovAliX in which Galapagosโ research and discovery capabilities and exclusively related employees based in Romainville, France,...
Drug Research
GSK, Scynexis Partner to Develop Brexafemme for Drug-Resistant Fungal Infections
Scynexisย entered into an exclusive agreement withย GSKย for Brexafemme (ibrexafungerp), a U.S. FDA approved antifungal for the treatment of vaginal yeast infections and vulvovaginal candidiasis (VVC).
Under...
Drug Research
WACKER, CordenPharma, LMU and HU Berlin Train Machine Learning Algorithm for the Formulation of RNA Actives
Together with Munichโs Ludwig Maximilian University (LMU) and the Humboldt University of Berlin (HU Berlin), Wacker Chemie AG and CordenPharma International GmbH have launched...
Drug Research
Cancer Drugs Info Full of Gaps – Regulatory Action Needed
Drug manufacturers are not able to provide Europeans with the required information to gauge the benefits and defects of oncology medicines. This is as...
Drug Research
Australian Cell Graft For Nervous System Gets Funding Boost
Griffith University, based in Australia, has gone on to conduct a world-first study when it comes to cell transplantation so as to repair nervous...
Drug Research
UK Life Sciences Manufacturing To Get Aided With ยฃ277m Funds
A ยฃ277 million joint government-industry finance package will assist four UK life sciences companies in moving forward with life sciences manufacturing initiatives.
The Life Sciences...
Drug Research
Quotient Sciences Supports Crinetics Pharmaceuticals with Fully Integrated Pediatric Development and Clinical Testing Program
Crinetics Pharmaceuticals, a pharmaceutical company that develops therapies for rare endocrine diseases, and Quotient Sciences, a drug development and manufacturing accelerator, have announced a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read













